PDT | website

Our Recent Posts

Dosie™ validated in I-PDT clinical trial to treat Malignant Central Airway Obstruction

Dosie™ can model moving light to improve outcomes of intracavitary PDT in fighting Mesothelioma

Dr. Mary Potasek presents on the topics of LALC and ACAO PDT clinical trials

Tags

Dosie™ validated in I-PDT clinical trial to treat Malignant Central Airway Obstruction

Cancers, May 2023 (Special Issue: Remote-Controlled Therapeutics for Cancer Therapy and Imaging) – Currently, there are no effective...

Dosie™ can model moving light to improve outcomes of intracavitary PDT in fighting Mesothelioma

SPIE BiOS, 2023 (Optical Methods for Tumor Treatment and Detection) – We introduce a new feature of our Dosie™ modeling software that...

Simphotek partners with Penn in fighting Mesothelioma

Simphotek partners with Penn in developing an In Situ System for Treatment of Mesothelioma

Simphotek announces selection as a MedTech company

Simphotek has been selected as one of the showcase companies for the 2020-2021 NCI SBIR Investor Initiatives. As a MedTech company, it...

Dosie™ adds modeling Interstitial Photodynamic Therapy (I-PDT)

International Photodynamic Association World Congress, 2019 (Boston, USA) – Simphotek announces a new addition to its simulation software...

Dosie™ modeling software predicts better PDT outcomes.

SPIE BiOS, 2019 (Optical Methods for Tumor Treatment and Detection) – We introduce our Dosie modeling software that helps in predicting...

Treatment planning and real-time dosimetry for I-PDT

Cancers, 2017 (Special Issue: Photodynamic Cancer Therapy) – Treatment planning and real-time dosimetry optimize and further advance the...

Simphotek advances treatment of cancer using light-drug interacitons

TechNews, Apr 2016 (NJ Tech Council) – Simphotek collaborates with leading cancer research institutions to address a critical unmet need:...

Simphotek accelerates PDT entry into the era of personalized medicine

New Jersey Tech Weekly, Jan 10, 2016 – What happens when you optimize a cancer treatment using software? A possible organ-sparing,...

State Resources Help Newark-based Simphotek Aid World’s Leading Cancer Centers

NJEDA, Oct 2015 (Feature article) – Simphotek advances light-based treatment of cancer. Simphotek is working with its academic partners...